샘플 요청 목록

 카트 문의
시장보고서
상품코드
1385633

세계의 골반장기탈출 수복 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(-2031년) - 치료법별, 용도별, 최종사용자별, 지역별

Pelvic Organ Prolapse Repair Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 233 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 골반장기탈출(POP) 수복 시장 규모는 지속적으로 성장하고 있으며, 2024년 매출은 4억 2,000만 달러에 달할 것으로 예상됩니다. 이 시장은 향후 5.23%의 CAGR로 성장하여 2031년 말에는 6억 달러에 달할 것으로 예상됩니다. 이 시장의 성장은 여성들 사이에서 골반저 장애의 유병률이 증가하고 있으며, 제조업체들이 안전하고 효과적이며 오래 지속되는 치료법 개발에 주력하고 있기 때문입니다.

질탈출증, 요실금, 간질성 방광염, 누공과 같은 골반저 질환을 경험하는 여성이 증가하고 있습니다. 이러한 질환은 수술적 및 비수술적 골반장기탈출 수복 치료에 대한 수요를 주도하고 있습니다.

로봇 수술을 포함한 최소 침습 수술이 기존 치료법을 대체하고 있습니다. 이러한 수술은 회복이 빠르고 합병증이 적습니다. 골반저 수복에서 합성 메쉬와 관련된 합병증은 생체 재료 및 세포 기반 치료법에 대한 연구로 이어지고 있으며, 이는 시장에 긍정적인 영향을 미칠 것으로 예상됩니다.

제조업체들은 위험과 부작용을 최소화하면서 골반장기탈출 수복 치료 옵션을 개선하기 위해 연구개발에 투자하고 있습니다. 다양한 세포주를 이용한 조직공학을 포함한 이러한 기술 혁신은 환자들에게 더 나은 치료 결과를 약속합니다.

제조업체들은 의료 기관과 제휴하거나 골반저 합병증 유병률이 높은 지역으로 진출해 시장 범위를 확대하고 있습니다. 또한, 골반저 질환과 치료법에 대한 환자들의 인식을 높이기 위한 교육적 노력을 기울이고 있습니다.

미국은 여성 골반저 장애의 높은 유병률로 인해 전 세계 골반장기탈출 수복 시장에서 큰 점유율을 차지하고 있습니다. 업계 진입이 활발히 이루어지고 환자 인구가 증가하면서 시장 확대에 기여하고 있습니다.

중국은 인구가 많기 때문에 POP 수술 환자 수가 많습니다. 의료 인프라와 첨단 의료 기술에 대한 투자로 국내 및 인근 국가에서 환자가 몰려와 시장 성장을 주도하고 있습니다.

헬스케어 연구개발을 중시하는 독일은 POP 치료의 혁신을 촉진하고 있습니다. 의료 서비스 제공자와 제조업체의 협력 관계와 지역 특화 전략이 시장 확대에 기여하고 있습니다.

본 보고서는 세계 골반장기탈출 수복 시장에 대해 조사했으며, 시장 개요와 함께 치료법별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등을 조사하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나와 러시아의 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 세계의 골반장기탈출 수복 시장 전망, 2018-2031년

  • 세계의 골반장기탈출 수복 시장 전망, 치료법별, 금액(100만 달러), 2018-2031년
  • 세계의 골반장기탈출 수복 시장 전망, 용도별, 금액(100만 달러), 2018-2031년
  • 세계의 골반장기탈출 수복 시장 전망, 최종사용자별, 금액(100만 달러), 2018-2031년
  • 세계의 골반장기탈출 수복 시장 전망, 지역별, 금액(100만 달러), 2018-2031년

제4장 북미의 골반장기탈출 수복 시장 전망, 2018-2031년

제5장 유럽의 골반장기탈출 수복 시장 전망, 2018-2031년

제6장 아시아태평양의 골반장기탈출 수복 시장 전망, 2018-2031년

제7장 라틴아메리카의 골반장기탈출 수복 시장 전망, 2018-2031년

제8장 중동 및 아프리카의 골반장기탈출 수복 시장 전망, 2018-2031년

제9장 경쟁 상황

  • 제조업체와 용도별 히트맵
  • 기업의 시장 점유율 분석, 2023년
  • 경쟁력 대시보드
  • 기업 개요
    • Johnson & Johnson Services, Inc.
    • Coloplast A/S
    • Dipromed Srl
    • Boston Scientific Corporation(American Medical Systems Inc.)
    • PFM medical ag
    • Promedon Group
    • Caldera Medical
    • Cook Medical
    • Medgyn Products, Inc.
    • Cooper Surgical, Inc.
    • DIMA S.L.
    • Digitimer Ltd.
    • Bray Group Ltd.
    • Medesign Ingenieur-Consulting GmbH
    • Panpac Medical Corp.

제10장 부록

ksm 23.12.05

The global pelvic organ prolapse (POP) repair market continues to witness substantial growth, with a revenue of US$ 420 million in 2024. It is projected to expand at a CAGR of 5.23%, reaching a valuation of US$ 600 million by the end of 2031. The market's growth is driven by the rising prevalence of pelvic floor disorders among women and manufacturers' focus on developing safe, effective, and long-lasting treatment options.

Key Drivers of the Pelvic Organ Prolapse Repair Market

Prevalence of Pelvic Floor Disorders: An increasing number of women are experiencing pelvic floor conditions such as vaginal prolapse, urinary incontinence, interstitial cystitis, and fistulae. These conditions are driving the demand for pelvic organ prolapse repair treatments, both surgical and non-surgical.

Minimally Invasive Techniques: Minimally invasive surgeries, including robotic procedures, are replacing traditional treatment methods. These procedures offer faster recovery and fewer complications. The complications associated with synthetic mesh in pelvic floor repair have led to research into biomaterials and cell-based therapies, which are anticipated to positively impact the market.

Research and Development: Manufacturers are investing in research and development efforts to improve treatment options for pelvic organ prolapse repair while minimizing risks and side effects. These innovations, including tissue engineering with various cell lines, promise better outcomes for patients.

Geographical Expansions: Manufacturers are expanding their market reach by collaborating with healthcare organizations and entering regions with a high prevalence of pelvic floor complications. They are also engaging in educational initiatives to raise awareness among patients about pelvic floor conditions and available treatments.

Barriers to Market Growth

Stringent Regulations: Stringent regulations and product recalls related to pelvic reconstruction have limited the availability of products. Reported side effects such as mesh erosion, infections, vaginal scarring, and recurrent urine incontinence have led to heightened scrutiny by regulatory bodies.

Availability of Non-Surgical Options: Some patients prefer non-surgical and conservative treatments such as pelvic floor exercises, pessaries, and physical therapy. The availability of these non-invasive options affects the demand for surgical procedures.

Limited Patient Awareness: Limited knowledge of pelvic floor conditions and available treatments among patients and healthcare workers has resulted in cases of undiagnosed and untreated POP.

Country-wise Market Insights

United States: The United States accounts for a significant share of the global pelvic organ prolapse repair market due to the high prevalence of pelvic floor disorders among women. Established industry players and a growing patient population contribute to market expansion.

China: China's large population results in a substantial patient pool for POP repair surgeries. Investments in healthcare infrastructure and advanced medical technologies are attracting patients from within the country and nearby nations, driving market growth.

Germany: Germany's strong emphasis on research and development in healthcare fosters innovation in POP repair treatments. Collaborations between healthcare providers and manufacturers, along with region-specific strategies, contribute to market expansion.

Competition Landscape

The pelvic organ prolapse repair market is highly competitive, with numerous local competitors offering products and services. Key players are focusing on research and development, expansion, and partnerships to meet patient demands and expand their market presence.

Key Companies Leading the Pelvic Organ Prolapse Repair Market:

  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation (American Medical Systems Inc.)
  • pfm medical ag
  • Betatech Medical
  • Promedon Group
  • Caldera Medical
  • Cook Medical
  • Medgyn Products, Inc.
  • CooperSurgical, Inc.
  • DIMA S.L.
  • Digitimer Ltd.
  • Bray Group Ltd.
  • Medesign Ingenieur-Consulting GmbH
  • Panpac Medical Corp.
  • For.me.sa.
  • Bioteque America Inc.
  • Bliss GVS Pharma
  • Panpac Medical Corporation
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co.
  • Kangge Medical
  • Integra Lifesciences
  • Wallach Surgical Devices
  • Medesign

Key Segments of Pelvic Organ Prolapse Repair Industry Research

Treatment:

  • Non-surgical
    • Pessary
    • Pelvic Floor Muscle Therapy
  • Surgical
    • Colpocleisis
    • Colporrhaphy
    • Sacrocolpopexy
    • Sacrohysteropexy
    • Uterosacral or Sacrospinous Ligament Fixation

Application:

  • Cystocele
  • Urethrocele
  • Enterocele
  • Uterine Prolapse
  • Posterior Vaginal Wall Prolapse (Dropped Rectum)

End User:

  • Hospitals
  • Specialized Clinics
  • Female Care Facilities

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Pelvic Organ Prolapse Repair Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 3.1. Global Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Non-surgical
        • 3.1.1.1.1. Pessary
        • 3.1.1.1.2. Pelvic Floor Muscle Therapy
      • 3.1.1.2. Surgical
        • 3.1.1.2.1. Colpocleisis
        • 3.1.1.2.2. Colporrhaphy
        • 3.1.1.2.3. Sacrocolpopexy
        • 3.1.1.2.4. Sacrohysteropexy
        • 3.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 3.2. Global Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cystocele
      • 3.2.1.2. Urethrocele
      • 3.2.1.3. Enterocele
      • 3.2.1.4. Uterine Prolapse
      • 3.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 3.3. Global Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialized Clinics
      • 3.3.1.3. Female Care Facilities
  • 3.4. Global Pelvic Organ Prolapse Repair Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 4.1. North America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. By Treatment
        • 4.1.1.1.1. Pessary
        • 4.1.1.1.2. Pelvic Floor Muscle Therapy
      • 4.1.1.2. Surgical
        • 4.1.1.2.1. Colpocleisis
        • 4.1.1.2.2. Colporrhaphy
        • 4.1.1.2.3. Sacrocolpopexy
        • 4.1.1.2.4. Sacrohysteropexy
        • 4.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 4.2. North America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cystocele
      • 4.2.1.2. Urethrocele
      • 4.2.1.3. Enterocele
      • 4.2.1.4. Uterine Prolapse
      • 4.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 4.3. North America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialized Clinics
      • 4.3.1.3. Female Care Facilities
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 4.4.1.2. U.S. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.3. U.S. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.4.1.4. Canada Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 4.4.1.5. Canada Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.6. Canada Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 5.1. Europe Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. By Treatment
        • 5.1.1.1.1. Pessary
        • 5.1.1.1.2. Pelvic Floor Muscle Therapy
      • 5.1.1.2. Surgical
        • 5.1.1.2.1. Colpocleisis
        • 5.1.1.2.2. Colporrhaphy
        • 5.1.1.2.3. Sacrocolpopexy
        • 5.1.1.2.4. Sacrohysteropexy
        • 5.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 5.2. Europe Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cystocele
      • 5.2.1.2. Urethrocele
      • 5.2.1.3. Enterocele
      • 5.2.1.4. Uterine Prolapse
      • 5.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 5.3. Europe Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialized Clinics
      • 5.3.1.3. Female Care Facilities
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Pelvic Organ Prolapse Repair Market By Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.2. Germany Pelvic Organ Prolapse Repair Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.3. Germany Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.4. U.K. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.5. U.K. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.6. U.K. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.7. France Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.8. France Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.9. France Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.10. Italy Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.11. Italy Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.12. Italy Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.13. Turkey Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.14. Turkey Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.15. Turkey Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.16. Russia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.17. Russia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.18. Russia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. By Treatment
        • 6.1.1.1.1. Pessary
        • 6.1.1.1.2. Pelvic Floor Muscle Therapy
      • 6.1.1.2. Surgical
        • 6.1.1.2.1. Colpocleisis
        • 6.1.1.2.2. Colporrhaphy
        • 6.1.1.2.3. Sacrocolpopexy
        • 6.1.1.2.4. Sacrohysteropexy
        • 6.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 6.2. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cystocele
      • 6.2.1.2. Urethrocele
      • 6.2.1.3. Enterocele
      • 6.2.1.4. Uterine Prolapse
      • 6.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 6.3. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialized Clinics
      • 6.3.1.3. Female Care Facilities
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.2. China Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.3. China Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.4. Japan Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.5. Japan Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.6. Japan Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.7. South Korea Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.8. South Korea Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.9. South Korea Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.10. India Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.11. India Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.12. India Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 7.1. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. By Treatment
        • 7.1.1.1.1. Pessary
        • 7.1.1.1.2. Pelvic Floor Muscle Therapy
      • 7.1.1.2. Surgical
        • 7.1.1.2.1. Colpocleisis
        • 7.1.1.2.2. Colporrhaphy
        • 7.1.1.2.3. Sacrocolpopexy
        • 7.1.1.2.4. Sacrohysteropexy
  • 7.2. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Cystocele
      • 7.2.1.2. Urethrocele
      • 7.2.1.3. Enterocele
      • 7.2.1.4. Uterine Prolapse
      • 7.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 7.3. Latin America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialized Clinics
      • 7.3.1.3. Female Care Facilities
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.2. Brazil Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.3. Brazil Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.4. Mexico Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.5. Mexico Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.6. Mexico Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.7. Argentina Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.8. Argentina Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.9. Argentina Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. By Treatment
        • 8.1.1.1.1. Pessary
        • 8.1.1.1.2. Pelvic Floor Muscle Therapy
      • 8.1.1.2. Surgical
        • 8.1.1.2.1. Colpocleisis
        • 8.1.1.2.2. Colporrhaphy
        • 8.1.1.2.3. Sacrocolpopexy
        • 8.1.1.2.4. Sacrohysteropexy
        • 8.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 8.2. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cystocele
      • 8.2.1.2. Urethrocele
      • 8.2.1.3. Enterocele
      • 8.2.1.4. Uterine Prolapse
      • 8.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 8.3. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialized Clinics
      • 8.3.1.3. Female Care Facilities
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.2. GCC Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.3. GCC Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.4. South Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.5. South Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.6. South Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.7. Egypt Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.8. Egypt Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.9. Egypt Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.10. Nigeria Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.11. Nigeria Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.12. Nigeria Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by Application Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Johnson & Johnson Services, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Coloplast A/S
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Dipromed Srl
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Boston Scientific Corporation (American Medical Systems Inc.)
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. PFM medical ag
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Promedon Group
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Caldera Medical
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Cook Medical
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Medgyn Products, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Cooper Surgical, Inc.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. DIMA S.L.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Digitimer Ltd.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Bray Group Ltd.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Medesign Ingenieur-Consulting GmbH
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Panpac Medical Corp.
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제